by Jordana Choucair | Dec 19, 2022 | Life Sciences
The Food and Drug Administration (FDA) declared a shortage of Eli Lilly & Co.’s diabetes drug Mounjaro. The FDA informed pharmacies that they should expect full shipment delays for 5-milligram doses. However, the University of Utah drug information service,...
by Jordana Choucair | Dec 19, 2022 | Life Sciences
The FDA Vaccines and Related Biological Products Advisory Committee will hold a key meeting on January 26 to discuss the state of the pandemic and whether COVID-19 vaccines need to be modified again to better limit the fast-changing virus. The FDA is looking to get...
by Jordana Choucair | Dec 19, 2022 | Mental Health
A Wall Street Journal article examines how the surge in digital mental health treatment instigated a decline in the quality of care. According to the article, many of the new digital mental health companies used “classic Silicon Valley tactics” such as using...
by Jordana Choucair | Dec 19, 2022 | Health IT, Opioid/Substance Use Disorders
Senators Roger Marshall and Jeanne Shaheen plan to introduce legislation that will require social media companies to report fentanyl activity to law enforcement. The legislation would add to House Republicans’ strategy to increase oversight of tech...
by Jordana Choucair | Dec 19, 2022 | Providers
Data recently released by the Association of American Medical Colleges (AAMC) shows that the number of medical school applicants dropped to pre-pandemic levels in the 2022-23 academic year. The number of Black matriculants increased 6.4 percent year over year from the...
by Jordana Choucair | Dec 16, 2022 | Life Sciences
AbbVie Inc is leaving the Pharmaceutical Research and Manufacturers of America (PhRMA) and the Biotechnology Innovation Organization, two of the most influential pharmaceutical trade groups. The pharmaceutical giant’s move comes as provisions in the Inflation...
Recent Comments